• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从临床病理学角度探讨乳腺癌患者中相关的ceRNA-HOTAIR通路。

associated ceRNA-HOTAIR pathway in breast cancer patients from clinicopathological perspective.

作者信息

Ercoşkun Pelin, Ağirbaşli Deniz, Velidedeoğlu Mehmet, Seven Mehmet, Kalayci Aysel

机构信息

Department of Medical Genetics, Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkiye.

Department of General Surgery, Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkiye.

出版信息

Turk J Med Sci. 2025 May 30;55(3):782-791. doi: 10.55730/1300-0144.6027. eCollection 2025.

DOI:10.55730/1300-0144.6027
PMID:40686703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12270293/
Abstract

BACKGROUND/AIM: Several epigenetic alterations are involved in the development of breast cancer. The long noncoding RNA HOTAIR and related RNAs play a role in initiation of breast cancer and are promising targets for diagnostic biomarker and therapeutic studies. In this study, we aimed to investigate associated ceRNA HOTAIR pathway in breast cancer patients.

MATERIALS AND METHODS

Forty breast cancer patients and ten healthy controls were included in this study, and then patients were divided into clinicopathologic groups. After total cell-free RNA isolation, expression levels of target RNAs were analysed by Real-Time PCR. The amount of gene expression was determined according to delta-delta Ct method and change in the expression was determined using the 2 method.

RESULTS

HOTAIR expression was significantly higher in the study group (especially in the ER negative group) than in the control group (p value = 0.006). When patients with relapse were compared with those without relapse, expression was significantly higher (p value = 0.048). There was a significant increase in miR-20a-5p expression (p value = 0.002) in the premenopausal group compared to the postmenopausal group, while there was a significant decrease in expression (p value = 0.002). A positive correlation between patient age and and a negative correlation between patient age and miR-20a-5p were found (respectively p value: 0.037 and p value: 0.006. Also, we found a negative correlation between and miR-20a-5p (p value: 0.027, correlation coefficient: -0.350).

CONCLUSION

To our knowledge, this study is the first to examine the association of the associated HOTAIR axis with breast cancer in cell-free RNA from peripheral blood of patients. Our findings emphasize the potential of the associated HOTAIR axis as a prognostic biomarker and therapeutic target, especially in ER negative, postmenopausal onset, and relapsed breast cancer.

摘要

背景/目的:多种表观遗传改变参与乳腺癌的发生发展。长链非编码RNA HOTAIR及相关RNA在乳腺癌的起始过程中发挥作用,是诊断生物标志物和治疗研究的有前景的靶点。在本研究中,我们旨在探究乳腺癌患者中相关的竞争性内源性RNA(ceRNA)HOTAIR通路。

材料与方法

本研究纳入40例乳腺癌患者和10例健康对照,然后将患者分为临床病理组。在分离出全部无细胞RNA后,通过实时定量聚合酶链反应(Real-Time PCR)分析靶RNA的表达水平。基因表达量根据ΔΔCt法确定,表达变化使用2−ΔΔCt法确定。

结果

研究组(尤其是雌激素受体(ER)阴性组)中HOTAIR的表达显著高于对照组(p值 = 0.006)。将复发患者与未复发患者进行比较时,HOTAIR的表达显著更高(p值 = 0.048)。与绝经后组相比,绝经前组中miR-20a-5p的表达显著增加(p值 = 0.002),而HOTAIR的表达显著降低(p值 = 0.002)。发现患者年龄与HOTAIR呈正相关,与miR-20a-5p呈负相关(p值分别为0.037和0.006)。此外,我们发现HOTAIR与miR-20a-5p呈负相关(p值:0.027,相关系数:−0.350)。

结论

据我们所知,本研究首次在外周血无细胞RNA中检测相关的HOTAIR轴与乳腺癌的关联。我们的研究结果强调了相关的HOTAIR轴作为预后生物标志物和治疗靶点的潜力,尤其是在ER阴性、绝经后发病和复发的乳腺癌中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ccb/12270293/46fe1702f9da/tjmed-55-03-782f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ccb/12270293/d29663476bc0/tjmed-55-03-782f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ccb/12270293/ba82a92771f6/tjmed-55-03-782f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ccb/12270293/46fe1702f9da/tjmed-55-03-782f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ccb/12270293/d29663476bc0/tjmed-55-03-782f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ccb/12270293/ba82a92771f6/tjmed-55-03-782f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ccb/12270293/46fe1702f9da/tjmed-55-03-782f3.jpg

相似文献

1
associated ceRNA-HOTAIR pathway in breast cancer patients from clinicopathological perspective.从临床病理学角度探讨乳腺癌患者中相关的ceRNA-HOTAIR通路。
Turk J Med Sci. 2025 May 30;55(3):782-791. doi: 10.55730/1300-0144.6027. eCollection 2025.
2
MiR-101-3p and miR-106b-5p roles in EMT pathway: prognostic and therapeutic insights for luminal breast cancer.MiR-101-3p和miR-106b-5p在EMT途径中的作用:腔面型乳腺癌的预后和治疗见解
J Egypt Natl Canc Inst. 2025 Jul 21;37(1):43. doi: 10.1186/s43046-025-00304-z.
3
Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer.整合蛋白质组学和转录组学分析揭示雌激素受体阳性/孕激素受体阳性与雌激素受体阳性/孕激素受体阴性乳腺癌之间的关键调控基因。
BMC Cancer. 2025 Jul 1;25(1):1048. doi: 10.1186/s12885-025-14451-y.
4
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Regulatory effects of lncRNA PVT1 on transcriptome in human breast cancer MDA-MB-231 cell line determined by in silico analyses.通过计算机分析确定长链非编码RNA PVT1对人乳腺癌MDA-MB-231细胞系转录组的调控作用。
Chromosoma. 2025 Jun 4;134(1):5. doi: 10.1007/s00412-025-00830-8.
7
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.乳腺密度、内分泌治疗与乳腺癌风险:预后和预测生物标志物综述。
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.
8
Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers.免疫组织化学检测切除修复交叉互补基因1(ERCC1)对三阴性乳腺癌新辅助化疗反应的预测价值
Breast J. 2025 Feb 18;2025:8410670. doi: 10.1155/tbj/8410670. eCollection 2025.
9
Variable roles of miRNA- and apoptosis-linked genes in invasive breast cancer: expression patterns, clinicopathological associations, and prognostic significance.miRNA与凋亡相关基因在浸润性乳腺癌中的可变作用:表达模式、临床病理关联及预后意义
Mol Biol Rep. 2025 Jul 11;52(1):703. doi: 10.1007/s11033-025-10739-1.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

本文引用的文献

1
The INAVA mRNA in Extracellular Vesicles Activates Normal Ovarian Fibroblasts by Phosphorylation-Ubiquitylation Crosstalk of HMGA2.细胞外囊泡中的INAVA mRNA通过HMGA2的磷酸化-泛素化串扰激活正常卵巢成纤维细胞。
Adv Sci (Weinh). 2025 Jul;12(25):e2500912. doi: 10.1002/advs.202500912. Epub 2025 Apr 23.
2
Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancer.基于ceRNA网络的三阴性乳腺癌预后模型的开发。
PeerJ. 2025 Feb 27;13:e19063. doi: 10.7717/peerj.19063. eCollection 2025.
3
LncRNA TCL6 regulates miR-876-5p/MYL2 axis to suppress breast cancer progression.
长链非编码RNA TCL6通过调控miR-876-5p/MYL2轴抑制乳腺癌进展。
Transl Oncol. 2025 Mar;53:102210. doi: 10.1016/j.tranon.2024.102210. Epub 2025 Jan 27.
4
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma.HMGA2表达可预测胰腺导管腺癌的亚型、生存率及治疗结果。
Clin Cancer Res. 2025 Feb 17;31(4):733-745. doi: 10.1158/1078-0432.CCR-24-2200.
5
Antisense Oligonucleotide Embedded Context Responsive Nanoparticles Derived from Synthetic Ionizable Lipids for lncRNA Targeted Therapy of Breast Cancer.基于合成可离子化脂质的反义寡核苷酸嵌入的上下文响应性纳米粒子用于乳腺癌 lncRNA 靶向治疗。
ACS Appl Mater Interfaces. 2024 Sep 4;16(35):45871-45887. doi: 10.1021/acsami.4c04893. Epub 2024 Aug 20.
6
The emerging role and mechanism of HMGA2 in breast cancer.HMGA2 在乳腺癌中新兴的作用和机制。
J Cancer Res Clin Oncol. 2024 May 16;150(5):259. doi: 10.1007/s00432-024-05785-4.
7
Long-Noncoding-RNA HOTAIR Upregulation is Associated with Poor Breast Cancer Outcome: A Systematic Review and Meta Analysis.长链非编码 RNA HOTAIR 上调与乳腺癌不良预后相关:系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1169-1182. doi: 10.31557/APJCP.2024.25.4.1169.
8
Soy-derived isoflavones as chemo-preventive agents targeting multiple signalling pathways for cancer prevention and therapy.大豆衍生的异黄酮作为靶向多种信号通路用于癌症预防和治疗的化学预防剂。
Br J Pharmacol. 2025 May;182(10):2259-2286. doi: 10.1111/bph.16353. Epub 2024 Mar 25.
9
Circulating ESR1, long non-coding RNA HOTAIR and microRNA-130a gene expression as biomarkers for breast cancer stage and metastasis.循环 ESR1、长链非编码 RNA HOTAIR 和 microRNA-130a 基因表达作为乳腺癌分期和转移的生物标志物。
Sci Rep. 2023 Dec 19;13(1):22654. doi: 10.1038/s41598-023-50007-5.
10
LncRNA HOTAIR as a ceRNA is related to breast cancer risk and prognosis.长链非编码 RNA HOTAIR 作为 ceRNA 与乳腺癌风险和预后相关。
Breast Cancer Res Treat. 2023 Aug;200(3):375-390. doi: 10.1007/s10549-023-06982-4. Epub 2023 Jun 9.